“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media "We welcomed more than 3,000 attendees, including ...

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning Virginia as a leader in biotechnology. Virginia Tech, Carilion Clinic, and the ...

Companies facing steep revenue losses will be seeking to refill their pipelines, creating a ripe environment for “the biotech innovation engine” as noted in a market report authored by Dr ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

AbbVie Inc., Amgen Inc., AstraZeneca Plc, BeiGene Ltd., BioMarin Pharmaceutical Inc., BioNTech SE, CSL Ltd., F. Hoffmann La Roche Ltd., Genmab AS, Gilead Sciences Inc ...

By fostering a culture that values agility, external focus, collaboration, and patient-centered innovation, biotech can help redefine what is possible. This is not just about the science — it is ...

“We’re already seeing the benefits of joining IBioIC as we set our sights on scaling up and broadening our impact” – Sander Nevejans, Seastex Scotland’s Industrial Biotechnology ...

Biotech Showcase™ 2025 Opens the Year with ... These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.